Skip to content

Bridging Community Gaps Photovoice

Randomized Trial of a Peer-led Intervention to Promote Community Living and Participation - The Bridging Community Gaps Photovoice

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03291717
Acronym
BCGP
Enrollment
197
Registered
2017-09-25
Start date
2017-09-05
Completion date
2020-09-11
Last updated
2020-09-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Mental Illness, Social Isolation

Keywords

Mental Illness, Community Participation, Stigma, Photovoice

Brief summary

The purpose of this study is to test a peer-led intervention intended to promote the community living and participation of individuals with psychiatric disabilities entitled Bridging Community Gaps Photovoice (BCGP). The intervention targets increasing community involvement of individuals with psychiatric disabilities through reduction in self-stigma and perceived stigma, enhancing opportunities for community participation, and support to achieve community participation goals.

Detailed description

The BCGP intervention is 6 months long and the investigators expect that participants will experience lower self and perceived stigma, increased community participation and sense of belonging, and improved psychosocial functioning and personal growth after the intervention. The intervention is comprised of a 12-week class that meets once a week for two hours, followed by three booster sessions - one per month in the three months following the class, and up to 24 sessions of individual support as needed throughout the 6 months provided on a weekly basis either in person or by phone. The purpose of the individual support is to reinforce the class activities and to ensure the participants meets their community participation goal. The proposed study is a randomized trial which will be conducted at Boston University Center for Psychiatric Rehabilitation (BUCPR) in Massachusetts, the Mental Health Center of Denver (MHCD) in Colorado, and the Greater Bridgeport Mental Health Center (GBMHC) in Connecticut.

Interventions

BEHAVIORALBridging Community Gaps Photovoice (BCGP)

Participants assigned to this group will be part of the 6-month long BCGP intervention, which involves a 12- week class that meets weekly, followed by three booster sessions - one per month in the three months following the class, and up to 24 sessions of individual support as needed throughout the 6 months provided on a weekly basis either in person or by phone. The BCGP classes follow a manualized curriculum with sessions that combine didactic information, Photovoice exercises, and group discussions to empower participants in pursuing community participation goals, all refined with input from individuals with a lived experience.

Sponsors

Mental Health Center of Denver
CollaboratorUNKNOWN
Connecticut State, Department of Mental Health and Addiction Services
CollaboratorOTHER_GOV
Riverside Community Care
CollaboratorUNKNOWN
Boston University Charles River Campus
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
OTHER
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

1. are 18 or older. 2. are recipients of services at research sites due to having a DSM-V diagnosis of mental illness, including dual diagnosis (dual diagnosis refers to co-occurring mental illness and alcohol/ substance use disorder). 3. are interested in enhancing their community participation. 4. are not currently receiving individual peer support services. 5. are able to read and write in English.

Exclusion criteria

1)Inability to give full and knowing consent.

Design outcomes

Primary

MeasureTime frameDescription
UCLA Loneliness ScaleChange from Baseline to 3 months to 6 months to 9 months to 12 monthsis a 20-item 4-point Likert-type scale, widely used measure of loneliness and social isolation. Cronbach's alpha coefficients ranging from .89 to .94.
Multi-Dimensional Assessment of Community ParticipationChange from Baseline to 3 months to 6 months to 9 months to 12 monthsConsists of a set of objective and subjective measures of community belonging, inclusion and participation.

Secondary

MeasureTime frameDescription
Approaches to Coping with Anti-StigmaChange from Baseline to 3 months to 6 months to 9 months to 12 months27-item instrument with a 4 point scale (strongly disagree to strongly agree) measuring strategies to cope with stigma: secrecy, withdrawal, educating, challenging, and distancing.
Personal Growth and Recovery ScaleChange from Baseline to 3 months to 6 months to 9 months to 12 months25-item, 4 point scale (strongly disagree to strongly agree) of items measuring psychosocial functioning and recovery.
Internalized Stigma of Mental Illness ScaleChange from Baseline to 3 months to 6 months to 9 months to 12 months29-item, 4-point scale from (strongly disagree to strongly agree) assesses behaviors, thoughts and feelings that are self-stigmatizing including alienation, stereotype endorsement, social withdrawal, stigma resistance.
Behavior and Symptom Identification Scale (BASIS - R)Change from Baseline to 3 months to 6 months to 9 months to 12 monthsA 24-item scale that measures: mood disturbances, anxiety, interpersonal and role functioning, daily living skills, psychotic symptoms, impulsivity and substance use
Community Goal Achievement ScaleChange from Baseline to 3 months to 6 months to 9 months to 12 monthsadapted from Goal Attainment Scale, provides a structured approach to determining goal achievement regardless of the type or uniqueness of goal .
The Stigma ScaleChange from Baseline to 3 months, 3 months to 6 months, 6 months to 9 months, 9 months to 12 months28 item, 5 point scale (strongly disagree to strongly agree) measuring experienced and anticipated stigma.

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026